Biotech | April 25, 2022
Shilpa Medicare receives NoC for biosimilar Aflibercept
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Sputnik Light is the first component of Sputnik V
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post
The recommendation has been sent to the DCGI for approval
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Subscribe To Our Newsletter & Stay Updated
